Prof Christophe Le Tourneau presents at ecancer's Milan Summit on Precision Medicine 2018 about implementing precision medicine in cancer care.
He discusses the benefits of benefits and applications of high throughput technologies in precision medicine.
He reviews their prognostic and predictive value using various trails as case studies.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine